A hot topic right now is precision diagnostics and part of that is CDx markers in immunohistochemistry. Come and listen to Emilia Andersson MD, PhD. Pathologist. Oncology lead EMEA-LATAM (Europe, Middle East, Africa, and Latin America) Roche Diagnostics International Ltd. who talks about the new biomarker FOLR1, which is used in tubo-ovarian cancer.